Biomarkers of Spontaneous Recovery From Traumatic Spinal Cord Injury
| Status: | Recruiting |
|---|---|
| Conditions: | Hospital, Orthopedic |
| Therapuetic Areas: | Orthopedics / Podiatry, Other |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 4/6/2019 |
| Start Date: | October 2015 |
| End Date: | September 2019 |
| Contact: | Ona Bloom, Ph.D. |
| Email: | obloom@northwell.edu |
| Phone: | 516-562-3839 |
The purpose of the study is to profile biochemical responses and measure functional recovery
in parallel, throughout the 1st year after spinal cord injury (SCI), within the same
participants. These responses and recovery will be evaluated in samples from people who have
had a spinal cord injury due to trauma (e.g. car accident or a fall) within the first year
after SCI. Specifically, the investigators will test the hypothesis that a subset of
inflammatory biomarkers correlate inversely with functional recovery. The investigators will
use these data to build a predictive model of functional recovery after SCI that incorporates
biomarkers that can be easily quantified in the clinic.
Total anticipated enrollment will be 100 participants with SCI across three different sites
(Northwell Health System (NY), The Kessler Institute for Rehabilitation (NJ), University of
Louisville (KY) and may enroll up to 30 participants without SCI.
in parallel, throughout the 1st year after spinal cord injury (SCI), within the same
participants. These responses and recovery will be evaluated in samples from people who have
had a spinal cord injury due to trauma (e.g. car accident or a fall) within the first year
after SCI. Specifically, the investigators will test the hypothesis that a subset of
inflammatory biomarkers correlate inversely with functional recovery. The investigators will
use these data to build a predictive model of functional recovery after SCI that incorporates
biomarkers that can be easily quantified in the clinic.
Total anticipated enrollment will be 100 participants with SCI across three different sites
(Northwell Health System (NY), The Kessler Institute for Rehabilitation (NJ), University of
Louisville (KY) and may enroll up to 30 participants without SCI.
At all study visits, a member of the study team (investigator) will collect basic demographic
and health information from the participant or the participant's medical record.
Study participants will have blood drawn at each study visit (approximately 2 tablespoons).
The participant will be asked to partake in 4 study visits over the course of 1 year. The
first visit will be within the first 0-14 days of SCI. The 2nd, 3rd, and 4th visits will be
3, 6, and 12 months after their spinal cord injury.
At study visits 2, 3 and 4, a study investigator will also perform some clinical evaluations
for research purposes to test how the participant is recovering the ability to perform
activities of daily living and move after spinal cord injury.
and health information from the participant or the participant's medical record.
Study participants will have blood drawn at each study visit (approximately 2 tablespoons).
The participant will be asked to partake in 4 study visits over the course of 1 year. The
first visit will be within the first 0-14 days of SCI. The 2nd, 3rd, and 4th visits will be
3, 6, and 12 months after their spinal cord injury.
At study visits 2, 3 and 4, a study investigator will also perform some clinical evaluations
for research purposes to test how the participant is recovering the ability to perform
activities of daily living and move after spinal cord injury.
Inclusion Criteria:
SCI Subject Inclusion Criteria: To be eligible for prospective enrollment, participants are
required to meet the following inclusion criteria:
- ≥18 years old with traumatic SCI
- Injury within 0-3 days post injury prior to enrollment
- All American Spinal Injury Association (ASIA) grade classification A-D.
- Neurological injury level C4-T10
Exclusion Criteria:
To be eligible for prospective enrollment, SCI subjects are required to not meet the
following exclusion criteria:
- Stage III-IV pressure ulcers
- Cancer, chemotherapy, neutropenia
- Pregnancy (all female trauma patients of childbearing years are given a pregnancy test
on admission as part of routine admitting labs) or lactation
- No known previous SCI
- Autoimmune disease
- Pre-existing neurological disease
We found this trial at
6
sites
1020 Walnut St
Philadelphia, Pennsylvania 19107
Philadelphia, Pennsylvania 19107
(215) 955-6000
Principal Investigator: James Harrop, MD
Phone: 215-955-1554
Thomas Jefferson University We are dedicated to the health sciences and committed to educating professionals,...
Click here to add this to my saved trials
Columbus, Ohio 43210
Principal Investigator: Jan Schwab, MD,P.h.D
Phone: 614-366-3877
Click here to add this to my saved trials
Louisville, Kentucky 40202
Principal Investigator: Max Boakye, MD
Phone: 502-582-7491
Click here to add this to my saved trials
Manhasset, New York 11030
Principal Investigator: Ona Bloom, Ph.D.
Phone: 516-562-3839
Click here to add this to my saved trials
Vancouver, British Columbia V6T 1W5
Principal Investigator: Brian Kwon, MD,Ph.D.
Phone: 604-875-4111
Click here to add this to my saved trials
West Orange, New Jersey 07052
Principal Investigator: Gail Forrest, Ph.D.
Phone: 973-324-3518
Click here to add this to my saved trials